Oncology & Hematology
Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines
Over the past decade, significant advances have improved our understanding of the genetic and molecular mechanisms that lead to cancer.
Expertise: Oncology & Hematology 104 results
Clinical Development
Celebrating World Cancer Day: An Interview with Leading Oncology Experts
Every year on February 4th, the world comes together to recognize World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). This day unites individuals, communities, and organizations in the fight against cancer while raising...
Oncology & Hematology
Building Your Oncology NDA Playbook: Key Insights for the Journey to Approval
Oncology & Hematology
ASCO
Oncology & Hematology
Clinical Trials in Oncology West
Clinical Development
Bringing an Oncology Asset to Market: In-House vs Outsource?
During the multifaceted journey of bringing a promising therapeutic to market, sponsors are faced with a critical choice—whether to manage asset development in-house or to outsource to a clinical research organization (CRO) partner. This decision can influence timelines, costs, control...
Oncology & Hematology
What is Logic-Gating and Why Does It Matter in CAR-T Therapy?
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for certain hematological malignancies, offering hope where conventional therapies have been exhausted. By reprogramming a patient's own T-cells to recognize and attack cancer cells, CAR-T therapy embodies the promise...